VANCOUVER, British Columbia, Oct. 15, 2012 /PRNewswire/ -- Insiderslab.com has issued insider trading reports and Equity Research for the following companies: Citigroup (NYSE:C), Hewlett-Packard (NYSE:HPQ), NPS Pharmaceuticals(NASDAQ:NPSP), eBay (NASDAQ:EBAY), ConocoPhillips(NYSE:COP), and Research In Motion (NASDAQ:RIMM).
(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)
Citigroup Inc. (NYSE:C): Citigroup Inc. (NYSE:C) is scheduled to report its third quarter 2012 financial results on Monday, October 15, 2012. By the end of September, Citigroup announced it has completed the sale of EMI Group's recorded music division, EMI Music, to Vivendi and its subsidiary, Universal Music Group. Shares of Citigroup dipped as much as 2.17% to US$34.75 in the last trading session while the stock traded within the range of US$34.66 – US$35.65. Citigroup's one-year range remained US$23.30 to US$38.40 with its market capitalization touching US$101.90 billion. There were 42.56 million shares of Citigroup exchanging hands as compared to its average daily volume of 36.00 million shares. Did Citigroup insiders like CEOs, CFOs, and Directors sell their shareholdings before the stock price plunged? Academic studies have shown that insiders traditionally make higher investment returns than ordinary investors. Want to find out how they do it?
Hewlett-Packard Company (NYSE:HPQ): At the last trading session, Hewlett-Packard Company (NYSE:HPQ) shares crossed above the 50-day moving average and settled at US$14.41 by climbing 1.12%. In the past year, the stock has traded within a range of US$14.02– US$30.00. Its price, as of the latest close, was up 3% compared with the 52-week low and was 108% below the 52-week high. The last session's volume of 25.36 million shares was down from the average daily trading volume of 30.05 million shares. Hewlett-Packard's market capitalization after the recent close was US$28.33 billion. Since Hewlett-Packard insiders such as CEOs, CFOs and Directors have better access to company non-public information, Insiderslab.com thinks that investors would be wise to pay close attention to their stock trading behaviors. Check this insider trade report for HPQ here.
NPS Pharmaceuticals, Inc.(NASDAQ:NPSP): Insiderslab.com found company Chief Medical Officer, Senior Vice President, Roger J. Garceau, sold 140,625 shares on October 3, at stock price US$9.51 for about US$1.34 million. Disclose date: October 5. NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) is a clinical-stage biopharmaceutical company with market capitalization of US$937.88 million. At the close of the trading day, shares of NPS Pharmaceuticals soared US$1.73 (or 18.97%) to settle at US$10.86. In the past 52 weeks, NPS Pharmaceuticals share prices have been bracketed by a low of US$4.35 and a high of US$11.22, and are now at US$10.86 (150% above that low price). Abnormal trading volume of NPS Pharmaceuticals was found reaching 11.86 million shares, 9.2 times heavier than usual day trading. Are NPS Pharmaceuticals insiders starting to take huge profits by selling shares or exercising stock options? Academic studies have shown that insiders traditionally make higher investment returns than ordinary investors. Want to find out how they do it?
Today Insiderslab.com also observed abnormal trade volume for the following companies; insiders may involve trading in these companies. It will take some time for insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar.
Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.
Insiderslab.com covers insider trade data in major stock markets in the U.S., Hong Kong, Mainland China, and Singapore. Insiderslab.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.